A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects with Diabetic Macular Edema. - (DIAMOND-2)
A phase 2/3 double-masked, randomized, 2 stage, multicenter study of the efficacy and safety of OCS-01 eye drops in subjects with diabetic macular edema. - (Diamond-1)
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age
100 Clinical Results associated with Pharmaceutical Research Associates India Pvt Ltd.
0 Patents (Medical) associated with Pharmaceutical Research Associates India Pvt Ltd.
100 Deals associated with Pharmaceutical Research Associates India Pvt Ltd.
100 Translational Medicine associated with Pharmaceutical Research Associates India Pvt Ltd.